
FDA Decision on Moderna's mRNA Flu Shot Nears Amid Regulatory Uncertainty
The FDA is set to decide on Moderna's mRNA flu shot by Wednesday, a ruling with major implications for mRNA research. This follows the agency's initial rejection and subsequent agreement to review the application, causing concern among investors and researchers, especially after HHS cut mRNA vaccine funding.















